Guggenhime Andrew
- SEC CIK
- 0001230724
In the past year, 3 open-market sale filings worth $1.64M and no purchases.
Current role at each company
- PCVX Vaxcyte, Inc.PRESIDENT AND CFOas of Sep 9, 2026
- CRBU Caribou Biosciences, Inc.Directoras of Feb 20, 2026
- MTCR Metacrine, Inc.Directoras of Sep 6, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.64M
- 3 filings
- Net
- −$1.64M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Guggenhime Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PCVX Vaxcyte, Inc.
PRESIDENT AND CFO32 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2021 (view filing) | Nov 18 | 4 days | Guggenhime AndrewPresident and CFO | SSale | −3.10K | $24.53 | −$76.0K | −49.8%3.13K after | 2 lots |
| Dec 28, 2021 (view filing) | Dec 23 | 5 days | Guggenhime AndrewPresident and CFO | SSale | −3.10K | $24.00 | −$74.4K | −49.8%3.13K after | |
| Mar 3, 2022 (view filing) | Mar 1 | 2 days | Guggenhime AndrewPresident and CFO | SSale | −6.20K | $24.00 | −$148.8K | −66.5%3.13K after | |
| Mar 22, 2022 (view filing) | Mar 18 | 4 days | Guggenhime AndrewPresident and CFO | SSale | −3.10K | $26.13 | −$81.0K | −7.1%40.6K after | |
| Apr 20, 2022 (view filing) | Apr 18 | 2 days | Guggenhime AndrewPresident and CFO | SSale | −3.10K | $24.05 | −$74.6K | −7.1%40.6K after | |
| May 20, 2022 (view filing) | May 18 | 2 days | Guggenhime AndrewPresident and CFO | SSale | −3.10K | $24.44 | −$75.8K | −6.8%42.2K after | 2 lots |
| Jul 12, 2022 (view filing) | Jul 8 | 4 days | Guggenhime AndrewPresident and CFO | SSale | −3.10K | $24.00 | −$74.4K | −6.8%42.2K after | |
| Jul 20, 2022 (view filing) | Jul 18 | 2 days | Guggenhime AndrewPresident and CFO | SSale | −3.10K | $24.53 | −$76.0K | −6.8%42.2K after | 2 lots |
| Aug 22, 2022 (view filing) | Aug 18 | 4 days | Guggenhime AndrewPresident and CFO | SSale | −3.10K | $25.26 | −$78.3K | −6.8%42.2K after | 2 lots |
| Aug 29, 2022 (view filing) | Aug 25-29 | 4 days | Guggenhime AndrewPresident and CFO | SSale | −36.0K | $28.00 | −$1.01M | −46.0%42.2K after | 3 lots |